Speaker illustration

Doctor Mustafa Omar Abdimalik

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Evaluating risk factors, biomarkers and management of myocarditis following treatment with checkpoint inhibitors. A retrospective analysis.

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: National registries for rare myocardial diseases


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb